Pfizer Inc. (NYSE:PFE – Get Free Report) was the target of some unusual options trading activity on Friday. Stock traders ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Persistent levels of spike protein from COVID-19 vaccines could be associated with a range of chronic symptoms like excessive ...

Director nominees with CEO experience have long featured in Board slates put forward by activist investors. Those candidates were typically from outs ...

Additional data from CheckMate 274 showed that adjuvant nivolumab benefits patients with muscle-invasive bladder cancer with ...

Tiny Michigan biotech startup CircNova has raised a $3.3 million seed round for its technology that uses AI to target ...

The AJ Bell team explores companies Smith & Nephews and Coda as they release full-year results in weekly outlook ...

The thing about separating the art from the artist is that people are typically a lot more inclined to do so if the “art” isn ...

At the beginning of May, Pfizer spun back out Esperion Therapeutics, which it had originally purchased for $1.3 billion in March 2004. Since the acquisition, most of Esperion's promising pipeline ...

At two Senate confirmation hearings, Kennedy played down his well-publicised questioning of the safety of childhood vaccines ...